Should we screen for CKD?
eGFR perspectives on the difference between Cystatin C and creatinine
Check out the summary on eGFR diference chat, done by NephJC intern Bogdan Agavriloaei
Las Perspectivas del estudio CRIC: el Resumen Visual
Basado en los datos del estudio CRIC, este análisis profundiza en si esa discordancia (TFGe dif) es solo “ruido”… o una señal clínica que hemos estado ignorando.
Echale un vistazo al resumen visual realizado por el equipo de internos de #NephJC Dr Sai Vani Yellampalli y Akshaya Jayachandran
Insights from the CRIC Study: Visual Abstract
Based on data from the CRIC study, this analysis dives deep into whether this lab mismatch is just noise… or a clinical signal we’ve been missing.
Check out the beautiful visual abstract made by our NephJC interns Sai Vani Yellampalli and Akshaya Jayachandran. Great team work!!!
Mind The Gap: When eGFR Creatinine and Cystatin C Disagree
NephJC Shorts: The end of the Fluid Wars?
NephJC Shorts: zilebesiran silencing hypertension via RNA interference
CONFIDENCE manifests: finerenone & empagliflozin – CKD power couple that’s redefining ‘renal romance’
Check out CONFIDENCE recap
A dose of CONFIDENCE: Building evidence for finerenone-empagliflozin synergy in diabetic kidney disease
CONFIDENCE Visual Abstract
Check out the beautiful visual abstract made by NephJC intern Michelle Fravel.
Resumen Visual Ensayo CONFIDENCE
El ensayo CONFIDENCE evaluó la combinación de finerenona + empagliflozina en ERC + DM2: mayor reducción de CACu a 180 días. ¿Estamos listos para iniciar la terapia combinada desde el principio?
Revisa el resumen visual por Michelle Fravel
NephJC Shorts: Salt reduction still lowers BP
NephJC Shorts: BedMed and Chronotherapy
Introducing NephJC Shorts
In just over a decade of critical appraisal on NephJC, we have done several experiments. Some of them have worked out phenomenally well, such as the Freely Filtered podcast. Others were not ready for the time, such as the Google Hangouts. We want to try another such experiment, and hope we receive feedback to decide if this is something worthwhile that we should continue doing.
There are many studies and many trials and many reviews, and many guidelines that are published in Nephrology every week. Indeed, it is a golden era for randomized controlled trials in Nephrology. On the other hand, NephJC only occurs twice a month. It does take a lot of work, with the detailed critical appraisal, readable summary, visual, abstracts, and the chats. Sometimes the occasional, irregularly irregular podcast. Hence, we cannot deal with all the worthwhile studies that are coming out.
Enter NephJC Shorts.
This week, we are publishing a few short blogs. The purpose here is to cover some notable studies in brief. They do not receive the full, long, NephJC treatment. The articles we choose are those that the NephJC editorial team fancies, but suggestions are welcome. Since these are a shorter format, we don’t do a deep dive into the methods and don’t have a long list of the limitations and strengths. Think of them as a pithy version of the usual NephJC blog. Feedback welcome!
Featured
The NephJC Editors
CAPTIVATE NephTrials Visual Abstract
Check out the beautiful visual abstract made by Kajaree Giri
Do nudges increase the use of GDMT in diabetic CKD?
Is tacrolimus superior to MMF in pediatric steroid sensitive nephrotic syndrome?
From single shots to strategy: How CAPTIVATE is reframing the NephTrials playbook
Ensayo NUDGE-CKD: El Resumen Visual
El estudio NUDGE-CKD evaluó si enviar cartas electrónicas con recomendaciones a médicos y pacientes podía aumentar el uso de tratamientos clave en enfermedad renal crónica (iSRAA o iSGLT2).
Revisa el resumen visual por Divya Bajpal
¿El resultado? Hoy en vivo por #NephJC!
The NUDGE-CKD Visual Abstract
Check out the beautiful visual abstract made by NephJC faculty Dr Divyia Bajpai